J&J raises U.S. drug prices

Jan 11, 2019

Reuters

Johnson & Johnson raised U.S. prices on around two dozen drugs, including psoriasis treatment, Stelara, prostate cancer drug, Zytiga, and blood thinner, Xarelto.

Most of the price increases were between 6 percent and 7 percent; the drugmaker said the average list price increase on its drugs will be 4.2 percent this year.

 J&J told Reuters  it is not planning to raise the prices on any more of its drugs in 2019.

J&J is not alone when it comes to price increases. According to Rx Savings Drugmakers, by January 10, pharmaceutical companies had raised prices on 490 drugs.

Want to get content like this in your inbox?  Subscribe to our eNewsletter here!

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments